Neoleukin Therapeutics, Inc. (NLTX) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Speaker 1: Good afternoon and thank you for joining us today for Neolucan Therapeutics Conference Call. Speaker 1: At this time, all participants are in listen-only mode. Speaker 1: Following the conclusion of the prepared remarks, we will conduct a question and answer session and instructions will follow at that time. Speaker 1: As a reminder, today's conference call is being recorded. Speaker 1: I would now like to turn the call over to Julie Rothman, Communications for Neolucan Therapeutics. Julie, please go ahead. Speaker 2: Thank you. Good afternoon and welcome to Neolucan Therapeutics year-end 2021 Speaker 2: conference call. Joining me on the call today from Neolucan are Jonathan Drockman, CEO, Speaker 2: Priti Patel, CMO, Speaker 2: and Sean Smith, Vice President, Finance. Speaker 2: Today's call is being recorded. It will be available for replay on the Investor Relations section of the Neolucan website approximately 2 hours after the call for at least 30 days. Speaker 2: Before we start, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Speaker 2: Such statements represent management's judgments, intentions, beliefs, and expectations about future events, Speaker 2: strategies, product candidates, and operating plans. All forward-looking statements Speaker 2: included in this presentation are made as of today and involve assumptions, risks, and uncertainties, Speaker 2: and actual results could differ materially from those anticipated in the forward-looking statements. Speaker 2: Neolucan undertakes no obligation to update or revise any forward-looking statements. Speaker 2: Please refer to the company's filings with the SEC, which are available from the SEC, or in the Neolucan website for informat...